The first Astrazeneca plc trade was made in Q2 2014. Since then Paul Tudor Jones II bought shares two more times and sold shares on four occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Astrazeneca plc anymore.
… prophylaxis (prevention) trial showed AstraZeneca ’s sipavibart (formerly AZD3152), … , Vaccines and Immune Therapies, AstraZeneca , said: “Immunocompromis...
EIN News Pharmaceuticals, 4 days agoLONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) Tuesday announced follow-up data for TOPAZ-1 Phase III trial showing IMFINZI plus chemotherapy demonstrated clinic...
Finanz Nachrichten, about 1 month ago… subset of non-small cell lung cancer (NSCLC), AstraZeneca has … limited-state small cell lung cancer (LS-SCLC). As … III non-small cell lung cancer , under...
EIN News Lung Cancer, about 1 month ago… the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) and … patients with advanced EGFR-mutated lung cancer , particularly the encou...
EIN News Lung Cancer, about 2 months ago